A new clinical trial shows that adjusting specific fatty acid intake through diet significantly reduces the frequency and intensity of persistent post-traumatic headaches (pPTH) in individuals with traumatic brain injury (TBI).
A new football helmet incorporating liquid shock absorbers has the potential to diminish the impact of head impacts by up to 33%.
Silvana Costa, PhD, investigates eye movements as a diagnostic of cognitive dysfunction present in co-occurring trauma.
Mount Sinai announces the opening of The Charles Lazarus Children’s Abilities Center, which aims to transform and shape the course of children’s rehabilitation.
Read More
The National Institute of Neurological Disorders and Strokes has allocated $16 million toward a 7-year, multicenter research project led by The Ohio State University Wexner Medical Center and College of Medicine that will compare inpatient rehabilitation treatments for traumatic brain injuries.
Read More
Researchers in Mount Sinai Health System’s Department of Rehabilitation and Human Performance have received a $2.9 million grant from the National Institutes of Health to study whether a first-of-its-kind brain implant can help restore function in severely paralyzed patients and improve their ability to communicate.
Read More
Shannon Motisi, PT, DPT, and Lauren Wright, PT, DPT, discuss how getting patients up and walking after stroke, TBI, and incomplete SCI is a goal that technology and the right intervention help achieve, in this feature for Rehab Management.
Read More
Traumatic brain injury is increasing in the age group of over-65s, and the most frequent causes are falls and no longer road traffic accidents, according to findings from a study published in BMJ Open.
Read More
Researchers from Boston University suggest they can predict how well a patient will recover from aphasia using computer modeling.
Read More
Following a successful pilot program, the EksoNR robotic exoskeleton from Ekso Bionics will be available at four of Kindred Healthcare’s long-term acute care hospitals in Florida: Green Cove Springs, Tampa/St. Pete, Fort Lauderdale, and Melbourne.
Read More
A recent study has found abnormal reactions between the brain and gastrointestinal tract (gut-brain axis) in moderate to severe chronic TBI patients. These patients may not be absorbing nutrients properly, and treatments need to be developed to address these issues, researchers suggest.
Read More
Revance Therapeutics Inc announces positive topline data from its JUNIPER Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical trial of its investigational drug candidate DaxibotulinumtoxinA for Injection for the treatment of adults with moderate to severe upper limb spasticity.
Read More
PHADER – a study testing whether electrical stimulation of the back of the throat (pharynx), using a treatment catheter, would improve swallowing in people with a recent stroke or head injury, or who had been in an intensive care unit and needed ventilation – suggests positive results, according to researchers.
Read More
In a study, researchers from the Spaulding Motion Analysis Lab at Spaulding Rehabilitation Hospital lay the groundwork for the design of “precision rehabilitation” interventions by using wearable technologies to track the motor recovery of individuals with brain injury. Read more at robohub.com.
Read More
Movendo Technology is partering with Kessler Foundation to explore potential applications for Movendo’s robotic platform hunova in rehabilitation research in populations with balance deficits caused by neurological illness or injury and aging.
Read More
A case report measuring the benefits of Myomo Inc’s MyoPro myoelectric orthosis, published recently in the Journal of Rehabilitation and Assistive Technologies Engineering, suggests that, “Despite long-standing traumatic brain injury, meaningful improvements in motor function were observed.”
Read More
The Center Foundation, a Central Oregon nonprofit providing sports medicine services to high school students, has launched a new home study course for medical professionals interested in earning continuing education credit while learning about the latest research and tools in concussion management.
Read More
Ekso Bionics Holdings Inc announces it has received 501(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for use with patients with acquired brain injury (ABI).
Read More